News

Peter Marks, the venerable head of the FDA’s Center for Biologics Evaluation and Research, has been forced out. In this ...
Watson’s two-part Season 1 finale has come and gone, and star Peter Mark Kendall broke down the episode with PopCulture.com and shared his hopes for Season 2. In Sunday’s episode, “Your Life’s Work, ...
Prasad, a University of California at San Francisco professor and epidemiologist, will replace Peter Marks, whom the Trump administration forced out in late March. Prasad, who is also a ...
The prosecution case against Peter Sullivan hinged on a combination of now-discredited bite mark and circumstantial evidence ...
Prasad replaces former CBER director Peter Marks, who was forced to resign by health secretary Robert F. Kennedy Jr. in March.
"To dismiss children's deaths due to infectious diseases that are preventable by vaccines as just expected or not a big deal, that's just not acceptable to me," said Dr. Peter Marks, in an ...
Prasad replaces Dr. Peter Marks, who served as the director of the Center for Biologics Evaluation and Research at the FDA and played a key role in launching Operation Warp Speed — the Trump ...
Season 1 of Watson is coming to a close, and Peter Mark Kendall spoke to PopCulture.com about what’s in store for the two-part finale. In the finale, “Your Life’s Work,” airing on Sunday, May 4 and ...
In the wake of the high-profile departure of Peter Marks, M.D., Ph.D., the FDA has a new leader for its Center for Biologics Evaluation and Research (CBER). FDA Commissioner Marty Makary ...
Peter Sullivan spent 38 years in prison for a murder he did not commit in the biggest miscarriage of justice in British ...
Prasad replaces Peter Marks, the longtime leader of the Center for Biologics Evaluation and Research (CBER), who resigned in March after clashing with Health and Human Services (HHS) Secretary ...
Last year, he accused his predecessor as the head of the CBER, Peter Marks, of being "either incompetent or corrupt" for allowing the approvals. More recently, Prasad has heaped praise on new FDA ...